Maciag P C - Advaxis Inc | 人才画像

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 105 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Iberdomide is Immune Stimulatory and Induces Deep Anti-Myeloma Activity Across Doses in Combination with Daratumumab in Patients with TNE NDMM from the CC-220-MM-001 Study

Michael Amatangelo,Maria Wang,Paulo Maciag,Anna Sureda Balari,Niels van de Donk,Sagar Lonial,Anita K. Gandhi,Nathan Martin

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S227-S227

引用0浏览0引用

Pharmacodynamic Changes in Tumor and Immune Cells Drive Iberdomide’s Clinical Mechanisms of Activity in Relapsed and Refractory Multiple Myeloma

Michael Amatangelo,Erin Flynt,Nicholas Stong, Pradipta Ray,Oliver Van Oekelen,Maria Wang,Maria Ortiz,Paulo Maciag,Teresa Peluso,Samir Parekh,Niels W. C. J. van de Donk,Sagar Lonial,Anjan Thakurta

CELL REPORTS MEDICINEno. 6 (2024)

引用0浏览0WOS引用

P-405 EXCALIBER-RRMM: A Phase 3, Two-Stage Trial of Iberdomide, Daratumumab, Dexamethasone (iberdd) Versus Daratumumab, Bortezomib, Dexamethasone (dvd) in Patients with Relapsed/Refractory Multiple Myeloma

Sagar Lonial,Hang Quach,Meletios Dimopoulos, Paula Rodríguez-Otero,Jesus Berdeja,Paul Richardson, Margee Kyada, Sakiko Kuroda,Shuyu Chu,Paulo Maciag,Patricia C. Abad,Juliane Morando,Niels van de Donk

Clinical Lymphoma Myeloma and Leukemia (2024): S268

引用0浏览0引用

Exposure-Response–Based Multiattribute Clinical Utility Score Framework to Facilitate Optimal Dose Selection for Oncology Drugs

Yiming Cheng,Shuyu Chu, Jie Pu,Min Chen,Kevin Hong,Paulo Maciag,Ivan Chan,Li Zhu,Akintunde Bello, Yan Li

Journal of clinical oncology official journal of the American Society of Clinical Oncologyno. 35 (2024): 4145-4152

引用0浏览0WOS引用

MM-520 Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Bortezomib (BORT) or Carfilzomib (CFZ) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the CC-92480-MM-002 Trial

Albert Oriol,Irwindeep Sandhu, Marc S. Raab,Darrell White, Richard LeBlanc,Noopur Raje, Enrique M. Ocio, Aurore Perrot, Thierry Facon, Cesar Rodriguez,Ralph Waesch,Michael Amatangelo,Zehua Zhou, Yue Wang,Tiziana Civardi,Phillip Koo,Paulo Maciag,Daniel Zhu,Jessica Katz, Paul Katz

Clinical Lymphoma Myeloma and Leukemia (2024)

引用0浏览0引用

OA-55 Iberdomide, Daratumumab, and Dexamethasone (iberdd) in Transplant-Ineligible (TNE) Newly Diagnosed Multiple Myeloma (NDMM): Results from the CC-220-MM-001 Trial

Anna Sureda Balari,Abdullah Khan,Albert Oriol,Mercedes Gironella Mesa,Faiz Anwer,Cristina Encinas Rodríguez,Brea Lipe, Paula Rodríguez-Otero,Michael Amatangelo,Kexin Jin,Thomas Solomon,Lilia Taningco,Alpesh Amin,Paulo Maciag,Sagar Lonial

Clinical Lymphoma Myeloma and Leukemia (2024): S35

引用0浏览0引用

MM-488 Iberdomide, Bortezomib, and Dexamethasone (ibervd) in Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): Results from the CC-220-MM-001 Trial

Darrell White,Brea Lipe, Mercedes Gironella,Ruben Niesvizky,Albert Oriol,Anna Sureda Balari, Manisha Bhutani,Cristina Encinas,Abdullah Khan,Michael Amatangelo, Kexin Jin,Thomas Solomon,Kevin Hong,Alpesh Amin,Paulo Maciag, Niels W.C.J. van de Donk,Sagar Lonial

Clinical Lymphoma Myeloma and Leukemia (2024)

引用0浏览0引用

P-335 Iberdomide is Immune Stimulatory and Induces Deep Anti-Myeloma Activity Across Doses in Combination with Daratumumab in Patients with TNE NDMM from the CC-220-MM-001 Study

Michael Amatangelo,Maria Wang,Paulo Maciag,Anna Sureda Balari,Niels van de Donk,Sagar Lonial,Anita K. Gandhi,Nathan Martin

Clinical Lymphoma Myeloma and Leukemia (2024): S227

引用0浏览0引用

OA-41 Iberdomide, Bortezomib, and Dexamethasone (ibervd) in Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): Results from the CC-220-MM-001 Trial

Darrell White,Brea Lipe,Mercedes Gironella Mesa,Ruben Niesvizky,Albert Oriol,Anna Sureda Balari,Manisha Bhutani,Cristina Encinas,Abdullah Khan,Michael Amatangelo,Kexin Jin,Thomas Solomon,Kevin Hong,Alpesh Amin,Paulo Maciag,Niels van de Donk,Sagar Lonial

Clinical Lymphoma Myeloma and Leukemia (2023)

引用0浏览0引用

A Phase 3, Two-Stage, Randomized Study of Iberdomide Maintenance Versus Lenalidomide Maintenance Post Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma: EXCALIBER-maintenance

Francesca Gay,Meletios Dimopoulos,Xiaojun Huang,Sagar Lonial,Karthik Ramasamy,Michael Amatangelo, Abdallah Abouihia,Mark Masin,Hina Maniar,Jorge Acosta,Paulo Maciag,Niels van de Donk

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S111-S111

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn